CD80
CD40
CD86
C-C趋化因子受体7型
趋化因子
细胞生物学
抗原呈递
树突状细胞
抗原提呈细胞
细胞毒性T细胞
免疫系统
生物
T细胞
化学
MHC II级
白细胞介素12
免疫学
趋化因子受体
生物化学
体外
作者
Thomas Luft,Petra Luetjens,Hubertus Hochrein,Tracey Toy,Kelly‐Anne Masterman,Mark Rizkalla,C R Maliszewski,Ken Shortman,Jonathan Simon Cebon,Eugene Maraskovsky
标识
DOI:10.1093/intimm/14.4.367
摘要
Type I IFN are immune modulatory cytokines that are secreted during early stages of infection. Type I IFN bridge the innate and the adaptive immune system in humans and mice. We compared the capacity of type I and II IFN to induce the functional maturation of monocyte-derived dendritic cells (MoDC). Extending our earlier observation that type I IFN promote DC maturation, we report that these cytokines also enhance DC differentiation by augmenting CD40 ligand (CD40L)-induced cytokine secretion by MoDC. Type I IFN alone were poor inducers of MoDC maturation as compared with other stimuli. They up-regulated the expression of HLA-DR, CD80, CD86, partially CCR7 but not CD83, partially reduced antigen-uptake function, increased the levels of IL-12p35 mRNA, and prolonged surface expression of peptide-MHC class I complexes for presentation to cytotoxic T lymphocytes, but did not induce migration towards CCL21 chemokine. However, type I IFN were potent co-factors for CD40L-mediated function. Here, they enhanced CD40L-mediated IL-6, IL-10 and IL-12p70 secretion. Furthermore, when combined with IL-1beta and/or IL-4, IFN-alpha2a type I IFN increased CD40L-mediated IL-12p70 production by 2- to 3-fold, and biased the IL-12 p40/p70 ratio towards the IFN-gamma inducing p70 heterodimer, this correlating with higher levels of IFN-gamma secretion by allogeneic T cell subsets and NK cells. Our results suggest that the rapid expression of CD40L, IFN and IL-1beta at sites of infection and inflammation can act in concert on immature DC, thereby linking innate and adaptive immune responses. In this way, type I IFN play a dual role as DC maturation factors and enhancers of CD40L-mediated DC activation.
科研通智能强力驱动
Strongly Powered by AbleSci AI